Skip to content

Drug interactions

Golimumab + Muromonab cd3

Severity: Major

Golimumab and Muromonab cd3: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Combining golimumab with the T-cell depleting antibody muromonab-CD3 produces profound combined immunosuppression. This raises the risk of serious opportunistic infections and possibly lymphoproliferative disorders.

What this interaction means in plain words

Golimumab and Muromonab cd3 can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive immunosuppression from TNF blockade and T-cell depletion.

What to do

Avoid concurrent use where an alternative exists. If unavoidable, monitor closely for infection and consider antimicrobial prophylaxis.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Golimumab and Muromonab cd3, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Golimumab with Muromonab cd3?

MediHelp rates the interaction as major. Golimumab and Muromonab cd3 can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Combining golimumab with the T-cell depleting antibody muromonab-CD3 produces profound combined immunosuppression. This raises the risk of serious opportunistic infections and possibly lymphoproliferative disorders.

How serious is the interaction between Golimumab and Muromonab cd3?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where an alternative exists. If unavoidable, monitor closely for infection and consider antimicrobial prophylaxis.

What other medicines interact with Golimumab?

MediHelp also lists interactions of Golimumab with, for example, Bcg vaccine live, Etanercept, Influenza virus vaccine quadrivalent intranasal. The full list is on the Golimumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in